We provide the financial, analytical, and clinical expertise necessary to develop collaborative strategies for managing risk, cost, and quality for all healthcare industry stakeholders.
This fast-growing segment of our healthcare system presents both challenges and opportunities for those who choose to participate.
The Terry Group’s healthcare experts and actuaries help payers and providers with both strategy and execution. We help with data aggregation, pricing, bid preparation, risk adjustments, and internal management and coordination.
Providers are assuming more risk. The transition to value-based care is not straightforward; it demands greater collaboration among financial management, clinical resources, quality experts and technological systems.
Payers are working to develop sustainable financial arrangements that reduce cost while improving the quality of care.
The Terry Group helps payers and providers with evaluating existing arrangements as well as providing a foundation for more effective contracting going forward.
Social Determinants of Health
SDOHs are proving to be effective ingredients in any risk adjustment methodology. Their growing use coincides with an increased focus on achieving improvements in quality outcomes while maintaining sustainable financial results.
The Terry Group helps payers and providers with improved stratification of risks in order to optimize strategic, quality and financial goals. Our diverse non-diagnostic data sources and our structured approach to data aggregation are essential inputs to our clinical and financial support of our clients’ goals.
Data Analytics and Risk Assessment
The Terry Group integrates data management and analytics, its extensive modeling capabilities and clinical expertise to help clients in both public (Medicare, Medicaid) and commercial applications of risk assessment.
Prescription Drug Analysis
Pharmacy benefits are a large and growing portion of our nation’s healthcare spend.
The Terry Group integrates pharmaceutical and actuarial expertise to help organizations navigate the complexities of drug benefits in pursuit of successful drug management programs.